Fellowship
Nuclear Medicine
The Nuclear Medicine Fellowship at Penn State Health Milton S. Hershey Medical Center is a one-, two- or three-year, ACGME-accredited program that admits one fellow per year.
Explore More
The Nuclear Medicine Fellowship at Penn State Health Milton S. Hershey Medical Center consists of a comprehensive curriculum in general nuclear medicine, positron emission tomography/computed tomography (PET/CT) and radionuclide therapy.
Program Overview
Nuclear medicine is the medical specialty that uses the tracer principle, most often with radiopharmaceuticals, to evaluate molecular, metabolic, physiologic and pathologic conditions of the body for the purposes of diagnosis, therapy and research. Commonly performed nuclear medicine studies include nuclear cardiac studies, bone imaging, hepatobiliary and gastrointestinal tract imaging, renal studies, thyroid scans and multiple types of tumor imaging. PET/CT imaging is performed for oncology, neurology and cardiology applications. PET detects alternations in glucose metabolism that occur in neoplastic and inflammatory conditions. Merging the PET data to a concurrently acquired CT scan allows for sensitive and accurate localization of aberrant glucose metabolism throughout the body.
Nuclear medicine also performs comprehensive diagnostic evaluation and therapy for a number of endocrine conditions including hyperthyroidism and thyroid cancer.
Two new leading-edge radionuclide therapies – Radium Ra-223 dichloride (Xofigo) and yttrium-90 (90Y) SIR-Spheres microspheres – are offered by Penn State Health Milton S. Hershey Medical Center’s Nuclear Medicine service.
Radium Ra-223 dichloride, an alpha-emitting radioactive therapeutic agent, is indicated for the treatment of patients with castration-resistant prostate cancer that has spread to bones and is causing symptoms. Xofigo therapy consists of monthly injections of the alpha-emitting treatment agent for up to six months.
90Y SIR-spheres microspheres are approved to treat colon and rectal cancer that has spread to the liver. SIR-Spheres microspheres treatments are performed as an outpatient procedure by a specially trained team of interventional radiologists and nuclear medicine physicians.
Learn More about the Fellowship
All positions for the 2022-2023 academic year for the Nuclear Medicine Residency have been filled, and the program is no longer accepting applications.
Applications for the 2023-2024 academic year will be accepted beginning in August 2023.
Contact and Leadership
Program Coordinator, Diagnostic Radiology Residency, Neuroradiology Fellowship and Nuclear Medicine Fellowship, Radiology
Mailing Address
Nuclear Medicine Fellowship
Department of Radiology
Penn State Health Milton S. Hershey Medical Center
500 University Dr.
P.O. Box 850, MC H066
Hershey, PA 17033
General Contact Information
Fax: 717-531-0006
